 WILMINGTON, Del., March 15, 2021 GLOBE NEWSWIRE -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. GenMark NASDAQ GM: GNMK regarding possible breaches of fiduciary duties and other violations of law related to GenMarks agreement to be acquired by Roche Holdings, Inc. Under the terms of the agreement, GenMarks shareholders will receive 24.05 in cash per share. 